The European Commission (EC) has approved Sanofi's Xenpozyme (olipudase alfa) as the first and only enzyme replacement therapy for the treatment of non-Central Nervous System (CNS) manifestations of Acid...

View the Online Magazine

Launches

Beckman Coulter partners with Smart4Diagnostics to close the data gap between blood collection and lab analysis

Beckman Coulter, a global clinical diagnostics leader, has announced a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood...

The green solution to wastewater sterilisation is black and white

The need to add chemical disinfectants to discarded liquids and wastewater may now be over, due to AstellBio’s new range of thermal Effluent Decontamination...

Beckman Coulter introduces antipsychotic drug testing to address unmet clinical need for more than 69m people living with serious mental conditions

Beckman Coulter, a global clinical diagnostics leader, will introduce new antipsychotic drug tests to laboratories and clinicians to address an unmet clinical need for...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Shionogi signs agreement with NHS England to begin innovative subscription payment model for reimbursement of its antibiotic, Fetcroja (Cefiderocol)

Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter "Shionogi"), today announced that Shionogi B.V. had signed an agreement with NHS England...

Lupin Healthcare announces availability of the first carbon neutral pMDI with Luforbec® 100/6 (beclometasone 100 mcg / formoterol 6 mcg) and establishes commitment to...

Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin Limited (Lupin), has announced that Luforbec (beclomethasone / formoterol) 100/6 pressurised metered dose inhaler (pMDI)...

WHO recommends successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator

WHO has made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk...

LogiPharma leads the way as Tower takes cold chain containers on the road

In its first appearance at the renowned LogiPharma conference, Tower Cold Chain is speaking about the key challenges in temperature-controlled logistics, as well as...

Approvals

Manufacturiung

Finance

Research & Development
Latest

Astellas and Sutro Biopharma collaborate to advance novel immunostimulatory antibody-drug conjugates

Astellas Pharma and Sutro Biopharma have announced a worldwide, strategic collaboration and licensing agreement focused on the discovery and development of novel immunostimulatory antibody-drug...

SureScreen Diagnostics, Guy’s and St Thomas’ and TestCard collaborate to trial monkeypox lateral flow test

A new lateral flow test that can detect monkeypox infections in humans in just 10 minutes is being trialled in London as part of...

New agreement paves way for development of first African-owned COVID-19 vaccine

One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two biotech companies - Afrigen Biologics and the Univercells...

Researchers find way to target cancer while protecting healthy tissue

Researchers have discovered how to target stem cells affected by leukaemia without causing harm to healthy stem cells, paving the way for new, safer...

Invectys, MD Anderson and CTMC announce strategic collaboration for CAR T cell therapy development

Invectys, The University of Texas MD Anderson Cancer Center and the Cell Therapy Manufacturing Center (CTMC), a joint venture between MD Anderson and National...

Appointments